Genetec Technology Berhad Future Growth
Future criteria checks 3/6
Genetec Technology Berhad is forecast to grow earnings and revenue by 14.3% and 12.8% per annum respectively. EPS is expected to grow by 14% per annum. Return on equity is forecast to be 14.5% in 3 years.
Key information
14.3%
Earnings growth rate
14.0%
EPS growth rate
| Semiconductor earnings growth | 27.8% |
| Revenue growth rate | 12.8% |
| Future return on equity | 14.5% |
| Analyst coverage | Low |
| Last updated | 03 Dec 2024 |
Recent future growth updates
Recent updates
Genetec Technology Berhad (KLSE:GENETEC) Shares Fly 25% But Investors Aren't Buying For Growth
Dec 08
Analysts Just Shaved Their Genetec Technology Berhad (KLSE:GENETEC) Forecasts Dramatically
Dec 03Here's Why Genetec Technology Berhad (KLSE:GENETEC) Can Manage Its Debt Responsibly
Nov 28Genetec Technology Berhad (KLSE:GENETEC) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Oct 23Genetec Technology Berhad's (KLSE:GENETEC) Returns On Capital Are Heading Higher
Sep 22Genetec Technology Berhad (KLSE:GENETEC) Analysts Are More Bearish Than They Used To Be
Aug 27Not Many Are Piling Into Genetec Technology Berhad (KLSE:GENETEC) Stock Yet As It Plummets 27%
Aug 19Is Genetec Technology Berhad (KLSE:GENETEC) A Risky Investment?
Aug 06Genetec Technology Berhad's (KLSE:GENETEC) P/E Still Appears To Be Reasonable
Feb 26Slowing Rates Of Return At Genetec Technology Berhad (KLSE:GENETEC) Leave Little Room For Excitement
Jan 15Genetec Technology Berhad's (KLSE:GENETEC) CEO Will Probably Have Their Compensation Approved By Shareholders
Sep 22Does Genetec Technology Berhad (KLSE:GENETEC) Deserve A Spot On Your Watchlist?
Feb 08Genetec Technology Berhad (KLSE:GENETEC) Is Investing Its Capital With Increasing Efficiency
Dec 28Does Genetec Technology Berhad (KLSE:GENETEC) Have A Healthy Balance Sheet?
Nov 17Investors Shouldn't Overlook Genetec Technology Berhad's (KLSE:GENETEC) Impressive Returns On Capital
Aug 16Genetec Technology Berhad (KLSE:GENETEC) Has A Pretty Healthy Balance Sheet
Jul 21Genetec Technology Berhad (KLSE:GENETEC) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 30Genetec Technology Berhad's (KLSE:GENETEC) Intrinsic Value Is Potentially 93% Above Its Share Price
Apr 28Why We Like The Returns At Genetec Technology Berhad (KLSE:GENETEC)
Mar 23Genetec Technology Berhad (KLSE:GENETEC) Seems To Use Debt Quite Sensibly
Feb 24Genetec Technology Berhad (KLSE:GENETEC) Seems To Use Debt Quite Sensibly
Nov 04The CEO Of Genetec Technology Berhad (KLSE:GENETEC) Might See A Pay Rise On The Horizon
Sep 08Genetec Technology Berhad's (KLSE:GENETEC) Robust Earnings Are Not All Good News For Shareholders
Aug 05Genetec Technology Berhad's (KLSE:GENETEC) Returns On Capital Are Heading Higher
Jul 30Is Genetec Technology Berhad (KLSE:GENETEC) Using Debt In A Risky Way?
Jun 11How Well Is Genetec Technology Berhad (KLSE:GENETEC) Allocating Its Capital?
Feb 10Why Genetec Technology Berhad's (KLSE:GENETEC) CEO Pay Matters
Jan 14Here's Why Genetec Technology Berhad (KLSE:GENETEC) Can Manage Its Debt Responsibly
Dec 24
Genetec Technology Berhad's (KLSE:GENETEC) Has Performed Well But Fundamentals Look Varied: Is There A Clear Direction For The Stock?
Dec 03Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2027 | 381 | 94 | 59 | 69 | 2 |
| 6/30/2026 | 328 | 77 | 35 | 45 | 2 |
| 6/30/2025 | 244 | 49 | 114 | 55 | 2 |
| 6/30/2024 | 278 | 69 | 16 | 34 | N/A |
| 3/31/2024 | 296 | 76 | 23 | 48 | N/A |
| 12/31/2023 | 291 | 69 | -50 | 42 | N/A |
| 9/30/2023 | 299 | 59 | -21 | 66 | N/A |
| 6/30/2023 | 297 | 66 | 29 | 113 | N/A |
| 3/31/2023 | 241 | 50 | 18 | 92 | N/A |
| 12/31/2022 | 288 | 70 | 49 | 52 | N/A |
| 9/30/2022 | 268 | 75 | -6 | -4 | N/A |
| 6/30/2022 | 256 | 67 | -68 | -66 | N/A |
| 3/31/2022 | 224 | 56 | -104 | -100 | N/A |
| 12/31/2021 | 178 | 37 | -94 | -86 | N/A |
| 9/30/2021 | 146 | 20 | -40 | -34 | N/A |
| 6/30/2021 | 125 | 6 | -19 | -14 | N/A |
| 3/31/2021 | 97 | -4 | 17 | 20 | N/A |
| 12/31/2020 | 92 | -6 | 12 | 14 | N/A |
| 9/30/2020 | 100 | 1 | -11 | -10 | N/A |
| 6/30/2020 | 75 | -1 | 2 | 4 | N/A |
| 3/31/2020 | 80 | 0 | 9 | 10 | N/A |
| 12/31/2019 | 86 | 4 | 5 | 7 | N/A |
| 9/30/2019 | 81 | 0 | 3 | 5 | N/A |
| 6/30/2019 | 86 | 1 | 12 | 13 | N/A |
| 3/31/2019 | 97 | 6 | -2 | -1 | N/A |
| 12/31/2018 | 112 | 10 | 14 | 14 | N/A |
| 9/30/2018 | 105 | 8 | 9 | 10 | N/A |
| 6/30/2018 | 105 | 6 | -2 | -1 | N/A |
| 3/31/2018 | 101 | 4 | N/A | 3 | N/A |
| 12/31/2017 | 90 | 2 | N/A | -15 | N/A |
| 9/30/2017 | 77 | -3 | N/A | -10 | N/A |
| 6/30/2017 | 73 | -3 | N/A | 14 | N/A |
| 3/31/2017 | 70 | -4 | N/A | 6 | N/A |
| 12/31/2016 | 69 | -3 | N/A | 4 | N/A |
| 9/30/2016 | 74 | -3 | N/A | 14 | N/A |
| 6/30/2016 | 97 | 1 | N/A | 34 | N/A |
| 3/31/2016 | 129 | 4 | N/A | 22 | N/A |
| 12/31/2015 | 161 | 8 | N/A | 23 | N/A |
| 9/30/2015 | 180 | 11 | N/A | 11 | N/A |
| 6/30/2015 | 169 | 9 | N/A | -12 | N/A |
| 3/31/2015 | 146 | 4 | N/A | -4 | N/A |
| 12/31/2014 | 116 | 0 | N/A | 10 | N/A |
| 9/30/2014 | 101 | -2 | N/A | 16 | N/A |
| 6/30/2014 | 107 | -1 | N/A | 9 | N/A |
| 3/31/2014 | 116 | 1 | N/A | 15 | N/A |
| 12/31/2013 | 112 | -11 | N/A | 20 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GENETEC's forecast earnings growth (14.3% per year) is above the savings rate (3.6%).
Earnings vs Market: GENETEC's earnings (14.3% per year) are forecast to grow faster than the MY market (10.3% per year).
High Growth Earnings: GENETEC's earnings are forecast to grow, but not significantly.
Revenue vs Market: GENETEC's revenue (12.8% per year) is forecast to grow faster than the MY market (6.3% per year).
High Growth Revenue: GENETEC's revenue (12.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: GENETEC's Return on Equity is forecast to be low in 3 years time (14.5%).
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 13:06 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Genetec Technology Berhad is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shafiq Kadir | CGS International |
| null null | CLSA |
| Ee Yap | CLSA |